Anti-G6PC3 monoclonal antibody

Pre-made anti-G6PC3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to G6PC3/G6PC3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0877-Ab-1/ GM-Tg-hg-IP0877-Ab-2Anti-Human G6PC3 monoclonal antibodyHuman
GM-Tg-rg-IP0877-Ab-1/ GM-Tg-rg-IP0877-Ab-2Anti-Rat G6PC3 monoclonal antibodyRat
GM-Tg-mg-IP0877-Ab-1/ GM-Tg-mg-IP0877-Ab-2Anti-Mouse G6PC3 monoclonal antibodyMouse
GM-Tg-cynog-IP0877-Ab-1/ GM-Tg-cynog-IP0877-Ab-2Anti-Cynomolgus/ Rhesus macaque G6PC3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0877-Ab-1/ GM-Tg-felg-IP0877-Ab-2Anti-Feline G6PC3 monoclonal antibodyFeline
GM-Tg-cang-IP0877-Ab-1/ GM-Tg-cang-IP0877-Ab-2Anti-Canine G6PC3 monoclonal antibodyCanine
GM-Tg-bovg-IP0877-Ab-1/ GM-Tg-bovg-IP0877-Ab-2Anti-Bovine G6PC3 monoclonal antibodyBovine
GM-Tg-equg-IP0877-Ab-1/ GM-Tg-equg-IP0877-Ab-2Anti-Equine G6PC3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0877-Ab-1/ GM-Tg-hg-IP0877-Ab-2; GM-Tg-rg-IP0877-Ab-1/ GM-Tg-rg-IP0877-Ab-2;
GM-Tg-mg-IP0877-Ab-1/ GM-Tg-mg-IP0877-Ab-2; GM-Tg-cynog-IP0877-Ab-1/ GM-Tg-cynog-IP0877-Ab-2;
GM-Tg-felg-IP0877-Ab-1/ GM-Tg-felg-IP0877-Ab-2; GM-Tg-cang-IP0877-Ab-1/ GM-Tg-cang-IP0877-Ab-2;
GM-Tg-bovg-IP0877-Ab-1/ GM-Tg-bovg-IP0877-Ab-2; GM-Tg-equg-IP0877-Ab-1/ GM-Tg-equg-IP0877-Ab-2
Products NameAnti-G6PC3 monoclonal antibody
Formatmab
Target NameG6PC3
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-G6PC3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0877-Ag-1Recombinant multi-species G6PC3/ SCN4/ UGRP protein
    ORF Viral VectorpGMLP003565human G6PC3 Lentivirus plasmid
    ORF Viral VectorvGMLP003565human G6PC3 Lentivirus particle
    ORF Viral VectorpGMLPm002303mouse G6pc3 Lentivirus plasmid
    ORF Viral VectorvGMLPm002303mouse G6pc3 Lentivirus particle


    Target information

    Target IDGM-IP0877
    Target NameG6PC3
    Gene ID92579,68401,303565,714276,490942,101097770,369023,100064862
    Gene Symbol and Synonyms0710001K01Rik,G6PC3,SCN4,UGRP
    Uniprot AccessionQ9BUM1,Q6AZ83,Q148G2
    Uniprot Entry NameG6PC3_HUMAN,G6PC3_RAT,G6PC3_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000141349
    Target ClassificationN/A

    The target: G6PC3, gene name: G6PC3, also named as SCN4, UGRP. This gene encodes the catalytic subunit of glucose-6-phosphatase (G6Pase). G6Pase is located in the endoplasmic reticulum (ER) and catalyzes the hydrolysis of glucose-6-phosphate to glucose and phosphate in the last step of the gluconeogenic and glycogenolytic pathways. Mutations in this gene result in autosomal recessive severe congenital neutropenia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.